DOWNLOAD
Cathflo® Dosing and Administration Card (25 pieces per pack)
Item # CAT/082815/0056(3)
A step-by-step pocket guide to Cathflo® FDA-approved dosing and administration. This 2-sided card measures 3.5” × 7.5”.
Please complete information below to place your order. If you would like to login, or create an account click here.
*Indicates a required field.
PROFESSION IN
MY PRACTICE*

INSTITUTION*

FIRST NAME*

LAST NAME*

EMAIL*
*
By submitting your order, you certify that you are a health care professional licensed in the United States or its territories and are indicating that you wish to receive information about our products. Genentech's intent is to only provide information to health care professionals licensed in the United States or its territories who would likely be treating patients within the FDA-approved indications for these products.
To download, please select and verify that you are a health care professional licensed in the United States or its territories and are indicating that you wish to receive information about our products.
FINISH
DOWNLOAD
IMPORTANT SAFETY INFORMATION

INDICATION

Cathflo®Activase®(alteplase) is indicated for the restoration of function to central venous access devices as assessed by the ability to withdraw blood.

IMPORTANT SAFETY INFORMATION

Contraindications

Cathflo Activase should not be administered to patients with known hypersensitivity to alteplase or any component of the formulation.

PRECAUTIONS

General

Certain causes of catheter dysfunction should be considered before treatment with Cathflo Activase (e.g. catheter malposition, mechanical failure, constriction by a suture and lipid deposits or drug precipitates within the catheter lumen). These types of conditions should be considered before treatment with Cathflo Activase.

Bleeding

The most frequent adverse reaction associated with all thrombolytics in all approved indications is bleeding.

Should serious bleeding in a critical location (e.g., intracranial, gastrointestinal, retroperitoneal, pericardial) occur, treatment with Cathflo Activase should be stopped and the drug should be withdrawn from the catheter.

Infections

Cathflo Activase should be used with caution in the presence of known or suspected infection in the catheter.

Hypersensitivity

Hypersensitivity, including urticaria, angioedema and anaphylaxis, has been reported in association with use of Cathflo Activase. Monitor patients treated with Cathflo Activase for signs of hypersensitivity and treat appropriately if necessary.

Adverse Reactions

In clinical trials, the most serious adverse events reported after treatment were sepsis, gastrointestinal bleeding, and venous thrombosis.

Please see accompanying full Prescribing Information for additional important safety information.